Artificial Intelligence
Vitamin C (Ascorbic Acid) Market Size 2022| readjusted size of US$ 1936.2 million by 2028, data is Up to date for global separately with Impact of domestic and global market: Review by Business Opportunities, Trends, | No. of pages: 90
PUNE, Oct. 14, 2022 (GLOBE NEWSWIRE) — “Vitamin C (Ascorbic Acid) Market” | No. of pages: 90 research report focus on overall information that can help to take decisions on current market situation. Ascorbic acid (Vitamin C), an essential nutrient found mainly in fruits and vegetables. The body requires ascorbic acid in order to form and maintain bones, blood vessels, and skin. Ascorbic acid also promotes the healing of cuts, abrasions and wounds; helps fight infections; inhibits conversion of irritants in smog, tobacco smoke, and certain foods into cancer-causing substances; appears to lessen the risk of developing high blood pressure and heart disease; helps regulate cholesterol levels; prevents the development of scurvy; appears to lower the risk of developing cataracts; and aids in iron absorption. Ascorbic acid can cause adverse reactions when taken with some drugs.
Vitamin C (Ascorbic Acid) Market Report Contains: –
- Complete overview of the global Vitamin C (Ascorbic Acid) Market
- Top Country data and analysis for United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Vitamin C (Ascorbic Acid) markets such as North America, Europe, Asia-Pacific, South America and Middle East and Africa
- Description and analysis of Vitamin C (Ascorbic Acid) market potential by type, Deep Dive, disruption, application capacity, end use industry
- impact evaluation of most important drivers and restraints, and dynamics of the global Vitamin C (Ascorbic Acid) market and current trends in the enterprise
- Detailed profiles of the Top major players in the industry, including. Shandong Luwei,Northeast Pharma,North China Pharma,Shandong Tianli,Ningxia Qiyuan,Zhengzhou Tuoyang,Henan Huaxing,Anhui Tiger,DSM,CSPC Pharma
Get a Sample Copy of the Report at – https://proficientmarketinsights.com/enquiry/request-sample/21607625
Vitamin C (Ascorbic Acid) Market Segmentation: –
researcher’s latest report provides a deep insight into the global Vitamin C (Ascorbic Acid) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
Vitamin C (Ascorbic Acid) Market Analysis and Insights: Global Vitamin C (Ascorbic Acid) Market
Due to the COVID-19 pandemic, the global Vitamin C (Ascorbic Acid) market size is estimated to be worth US$ 1461.4 million in 2022 and is forecast to a readjusted size of US$ 1936.2 million by 2028 with a CAGR of 4.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Food Grade accounting for % of the Vitamin C (Ascorbic Acid) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Food & Beverage segment is altered to an % CAGR throughout this forecast period.
Global Vitamin C (Ascorbic Acid) main players are DSM, CSPC Pharma, Shandong Luwei, Northeast Pharma, etc. Global top four manufacturers hold a share over 80%. China is the largest market, with a share nearly 85%.
Inquire or Share Your Questions If Any Before the Purchasing This Report – https://proficientmarketinsights.com/enquiry/pre-order-enquiry/21607625
Global Vitamin C (Ascorbic Acid) Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Vitamin C (Ascorbic Acid) Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Vitamin C (Ascorbic Acid) Market segments help decision-makers direct the product, sales, and marketing strategies, and can power your product development cycles by informing how you make product offerings for different segments.
Segment by Type
- Food Grade
- Pharmaceutical Grade
- Feed Grade
Segment by Application
- Food & Beverage
- Pharmaceuticals & Healthcare
- Feed
- Cosmetics
Market segment by Region/Country including: –
- North America (United States, Canada, and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.)
- South America (Brazil, Argentina, Colombia, etc.)
- Middle East & Africa (South Africa, UAE, Saudi Arabia, etc.)
Key Players in the Vitamin C (Ascorbic Acid) Market: –
- Shandong Luwei
- Northeast Pharma
- North China Pharma
- Shandong Tianli
- Ningxia Qiyuan
- Zhengzhou Tuoyang
- Henan Huaxing
- Anhui Tiger
- DSM
- CSPC Pharma
Get a Sample Copy of the Report at – https://proficientmarketinsights.com/enquiry/request-sample/21607625
Key Benefits of Vitamin C (Ascorbic Acid) Market Research Report:
- Types, applications, regions, and key players covered in the study
- Industry drivers, restraints, and opportunities covered in the study
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Artificial Intelligence AI Chips Market
- Sales, price, revenue, market share, and growth rate are covered in the report sales channels, distributors, traders, dealers, etc. are covered in the report
Detailed TOC of Global Vitamin C (Ascorbic Acid) Market Research Report 2022
1 Vitamin C (Ascorbic Acid) Market Overview
1.1 Product Overview and Scope of Vitamin C (Ascorbic Acid)
1.2 Vitamin C (Ascorbic Acid) Segment by Type
1.2.1 Global Vitamin C (Ascorbic Acid) Market Size Growth Rate Analysis by Type 2022 VS 2028
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.2.4 Feed Grade
1.3 Vitamin C (Ascorbic Acid) Segment by Application
1.3.1 Global Vitamin C (Ascorbic Acid) Consumption Comparison by Application: 2022 VS 2028
1.3.2 Food & Beverage
1.3.3 Pharmaceuticals & Healthcare
1.3.4 Feed
1.3.5 Cosmetics
1.4 Global Market Growth Prospects
1.4.1 Global Vitamin C (Ascorbic Acid) Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Vitamin C (Ascorbic Acid) Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Vitamin C (Ascorbic Acid) Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Vitamin C (Ascorbic Acid) Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 China Vitamin C (Ascorbic Acid) Estimates and Forecasts (2017-2028)
1.5.3 Europe Vitamin C (Ascorbic Acid) Estimates and Forecasts (2017-2028)
1.5.4 North America Vitamin C (Ascorbic Acid) Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Vitamin C (Ascorbic Acid) Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Vitamin C (Ascorbic Acid) Revenue Market Share by Manufacturers (2017-2022)
2.3 Vitamin C (Ascorbic Acid) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Vitamin C (Ascorbic Acid) Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Vitamin C (Ascorbic Acid) Production Sites, Area Served, Product Types
2.6 Vitamin C (Ascorbic Acid) Market Competitive Situation and Trends
2.6.1 Vitamin C (Ascorbic Acid) Market Concentration Rate
2.6.2 Global 5 and 10 Largest Vitamin C (Ascorbic Acid) Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Vitamin C (Ascorbic Acid) Market Share by Region (2017-2022)
3.2 Global Vitamin C (Ascorbic Acid) Revenue Market Share by Region (2017-2022)
3.3 Global Vitamin C (Ascorbic Acid) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 China Vitamin C (Ascorbic Acid) Production
3.4.1 China Vitamin C (Ascorbic Acid) Production Growth Rate (2017-2022)
3.4.2 China Vitamin C (Ascorbic Acid) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Vitamin C (Ascorbic Acid) Production
3.5.1 Europe Vitamin C (Ascorbic Acid) Production Growth Rate (2017-2022)
3.5.2 Europe Vitamin C (Ascorbic Acid) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 North America Vitamin C (Ascorbic Acid) Production
3.6.1 North America Vitamin C (Ascorbic Acid) Production Growth Rate (2017-2022)
3.6.2 North America Vitamin C (Ascorbic Acid) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Explore Full Report With Detailed TOC Here: https://proficientmarketinsights.com/TOC/21607625#TOC
1.To study and analyze the global Vitamin C (Ascorbic Acid) consumption (value) by key regions/countries, product type and application
2.To understand the structure of Vitamin C (Ascorbic Acid) market by identifying its various sub segments.
3.Focuses on the key global Vitamin C (Ascorbic Acid) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter’s five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Vitamin C (Ascorbic Acid) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Vitamin C (Ascorbic Acid) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global Vitamin C (Ascorbic Acid) market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the Vitamin C (Ascorbic Acid) market and its impact in the global market.
Learn about the Vitamin C (Ascorbic Acid) market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the Vitamin C (Ascorbic Acid) market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Purchase this Report (Price 2900 USD for a Single-User License) – https://proficientmarketinsights.com/purchase/21607625
About Proficient market insights:
Proficient market insights is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.
DALIAN, China, July 1, 2024 /PRNewswire/ — “AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry.” At the 15th Annual Meeting of the New Champions, also known as Summer Davos, Ms. Gong Rujing (Yingying), Chairwoman and Founder of Yidu Tech, was invited as a distinguished representative of the healthcare technology sector. She shared her unique insights into the future of AI in healthcare during the thematic dialogue on “Healthcare Analytics, Not Moving Fast Enough.”
This year marks the 10th anniversary of Yidu Tech and Ms. Gong Rujing’s decade-long dedication to the healthcare industry. From the inception of her entrepreneurial journey 10 years ago, she has been driven by the mission to leverage the power of technology to deliver precise healthcare to every individual.
Ms. Gong described the past decade as a journey filled with miracles and achievements. During this period, Yidu Tech has progressively established close collaborations with key stakeholders in the healthcare industry, including government agencies, hospitals, pharmaceutical companies, insurance firms, experts, and clinicians. As of March 31, 2024, Yidu Tech’s “AI Medical Brain” YiduCore has been authorized to process and analyze over 5 billion medical records, covering more than 2,500 hospitals.
In AI-powered clinical research, Yidu Tech has supported researchers and clinicians in producing over 240 high-level papers, accelerating the application of research outcomes. Additionally, Yidu Tech provides clinical trial services to globally renowned pharmaceutical companies, helping them optimize trial processes, reduce costs, and bring new drugs to market more swiftly, ultimately benefiting patients. In healthcare management, Yidu Tech’s AI technology plays a crucial role by analyzing vast amounts of medical data to provide comprehensive decision support to healthcare administrators, helping them optimize resource allocation and improve service efficiency.
“We are now entering a new era of AI technology.” The development of large language model technologies has opened up new possibilities across various industries. Yidu Tech has independently developed a large language model specific to the medical field and is advancing its application across the entire healthcare industry chain. The goal is to promote further progress and innovation through new AI technologies. However, Ms. Gong also emphasized that the healthcare industry is professional, complex, and sensitive, and the application of new technologies must address challenges such as data security, privacy protection, and ethics.
“Data security and privacy protection are fundamental to the development of AI technology and medical big data technology. We must ensure that all stakeholders are satisfied with compliance, security, accessibility, and privacy protection.”
“AI technology still has a long way to go.” She called on policymakers, healthcare institutions, and technology companies to work together to realize the immense potential of healthcare data. Ms. Gong highlighted that building trust is key, and enhancing data operability is essential to fully unleash the power of data. “It’s not just about better data quality; it’s about a better future for health.”
View original content:https://www.prnewswire.co.uk/news-releases/transforming-healthcare-with-ai-yidu-techs-gong-rujing-at-summer-davos-302186561.html
Artificial Intelligence
Yidu Tech’s FY2024 results: existing business achieves first full-year profit on adjusted EBITDA
HONG KONG, July 1, 2024 /PRNewswire/ — On June 27, 2024, Yidu Tech Inc. (the ”Company” or ”Yidu Tech”) (2158.HK), a leader in China’s AI medical industry, announced its results for the 2024 fiscal year. During the reporting period, the Company recorded revenue of RMB 807.1 million. Gross profit margin in FY2024 increased to 42.1% from 34.1% in FY2023, representing an increase of 8 percentage points, hitting a record high. Adjusted net loss narrowed from RMB 448.7 million in FY2023 to RMB158.1 million, down 64.8% year-on-year. The management of Yidu Tech said at the annual results conference the next day that excluding strategic investments in proprietary large language model, non-cash items, and non-operating items, the adjusted EBITDA for our current business has achieved profit, moving from a RMB 327 million loss to a profit of RMB 31.1 million for the first time this fiscal year.
Management added that as of market close on June 27, the Company’s P/B ratio has decreased to 1.06. Not including the valuation of its domestic and international businesses, its market value is still lower than its fund reserves on hand. As such, management believes that the Company’s share price is still severely undervalued. Notably, renowned sovereign fund BIA has continually increased its shareholding of Yidu Tech by 21.50% over the past two months. The management is confident in the Company’s long-term growth potential and hopes to continually create innovative technologies and increase returns to its shareholders.
In FY2024, Yidu Tech focused on its core business, improving internal operating efficiency and earning quality. Among its earnings, revenue from its big data platform and solutions segment reached RMB 313.6 million, an increase of 41.4% year-on-year. Revenue from its life science solutions segment reached RMB 324.0 million, up 28.1% year-on-year and the gross margin increased by 14.6 percentage points to a historical high of 32.1%. Revenue from its health management platform and solutions segment reached RMB 169.5 million, and the gross profit margin of this segment was 58.1%, representing a year-on-year increase of 17.4 percentage points.
During the reporting period, the Company has continued the development and training of large language model in the medical vertical field based on 500 billion fine-trained Tokens, with model training for 6B, 13B, and 70B parameters completed.
View original content:https://www.prnewswire.co.uk/news-releases/yidu-techs-fy2024-results-existing-business-achieves-first-full-year-profit-on-adjusted-ebitda-302185986.html
Artificial Intelligence
Lucinity’s AI Innovation Recognized at Microsoft’s Prestigious Global Partner Awards 2024
REYKJAVIK, Iceland, June 28, 2024 /PRNewswire/ — Lucinity has been recognized as a finalist in the AI Innovation category at the prestigious Microsoft Global Partner Awards 2024, recognizing its breakthrough AI solution and contribution to financial security through its collaboration with Microsoft.
Lucinity beat more than 4,700 companies to be named a finalist at the annual Microsoft Global Partner Awards, which highlights Lucinity’s achievements as a Microsoft partner in optimizing business processes, improving customer experiences, and opening new pathways for digital transformation.
This achievement comes in addition to winning two prestigious awards at Microsoft Partner Awards 2024 last month, including Partner of the Year – Iceland, and the Sustainability and Social Impact award.
The accolade recognizes Lucinity’s significant advancements in AI for financial crime operations, particularly through their AI-powered copilot, Luci. This innovative solution utilizes Microsoft Azure OpenAI technology to integrate advanced generative AI into financial crime investigations and regulatory compliance, optimizing processes and saving significant time and resources for financial institutions.
The Lucinity platform streamlines compliance, provides instant insights, and reduces typical investigation times from three hours to just 30 minutes. The technology can also save financial institutions an estimated $100 million in productivity savings, as well as savings in training and recruitment.
Microsoft comments on Lucinity’s award recognition, saying “Financial crime profoundly impacts our global community, with far-reaching economic, security, and social implications. It can harm a country’s reputation and increase exposure to criminal activities, emphasizing the critical need for robust anti-money laundering initiatives and persistent vigilance. Lucinity, with their innovative AI solutions, has really tried to combat this huge global challenge. They use ‘Human AI’ to enhance financial crime prevention, combining AI with human expertise for efficient, user-friendly solutions. Additionally, Lucinity has developed a tool called Luci, an AI-powered copilot that helps transform financial crime prevention from a process that took hours to one that takes minutes.”
“Being recognized as a finalist at the Microsoft Global Partner Awards is validation of our impactful collaboration with Microsoft in financial crime operations. Our partnership has been pivotal for our innovations, enabling us to use Azure OpenAI to bring tools like Luci to life and deliver impactful results for our clients,” says Guðmundur Kristjánsson, Founder & CEO of Lucinity.
Contact:Name: Celina PabloEmail: [email protected]: +354 792 4321
Logo: https://mma.prnewswire.com/media/2208676/4669079/Lucinity_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/lucinitys-ai-innovation-recognized-at-microsofts-prestigious-global-partner-awards-2024-302186091.html
-
Artificial Intelligence6 days agoRelativity Announces General Availability Date for its Generative AI-Powered Review Solution at Relativity Fest London
-
Artificial Intelligence6 days agoSKAN, the Wellcome Sanger Institute and University of Newcastle to study early stem cell mutations in rare blood disorder
-
Artificial Intelligence6 days agoCOMPREDICT Secures $15M Series B Funding Round Led by Woven Capital
-
Artificial Intelligence6 days agoAI Revolution Accelerates: North American Tech Companies Lead Amid Regulatory Changes
-
Artificial Intelligence3 days ago
CO2 AI Launches First Solution to Compute Product Emissions at Scale
-
Artificial Intelligence3 days ago
North American grocery retailer digitizes stores with Pricer Plaza in 90 MSEK order
-
Artificial Intelligence2 days agoAsia Pacific View: Foreigners Looking for the Most Practical Smart Technology at the 2024 World Intelligence Expo
-
Artificial Intelligence3 days ago
Spotlight on Authentic AI: Developers Making Real Contributions Beyond AI Washing Claims
